Form 4: Maravai Lifesciences Holdings CEO Reports Stock Transaction
Insider Transaction (Form 4)
Bernd Brust, Chief Executive Officer and a Director of Maravai Lifesciences Holdings, Inc., reported a transaction in 29,250 shares of common stock on August 10, 2026.
Summary
- Tax/exercise-price withholding: disposed of 29,250 Class A Common Stock at $6.23 ($182,228) on August 10, 2026; holds 1,590,499 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Bernd Brust — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Tax/exercise-price withholding | Class A Common Stock | 29,250 | $6 | $182.2K | 1,590,499 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Tax/exercise-price withholding (29,250 shares) |
Keywords
insider transaction, Form 4, MRVI, MARAVAI LIFESCIENCES HOLDINGS, INC., neutral, Bernd Brust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.